Cabaletta Bio Inc

NASDAQ:CABA   4:00:00 PM EDT
17.06
-0.09 (-0.52%)
6:24:26 PM EDT: $17.34 +0.28 (+1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cabaletta Bio Inc Stock, NASDAQ:CABA

2929 Arch Street, Suite 600, Philadelphia, Pennsylvania 19104
United States of America
Phone: +1.267.759.3100
Number of Employees: 103

Description

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.